Review: Patients Can Safely Switch to Biosimilars
Researchers in this review suggest clinical trials of biosimilars include switching studies to assess the pharmacokinetics of the biosimilar candidate.
Study: Coverage Restrictions One Reason for Lower Biosimilar Adoption
Biosimilars have the potential to lower costs, but the adoption has been slower than expected, a recent study finds.
2 Clarke Drive Cranbury, NJ 08512